Clinuvel Pharmaceuticals Ltd
ASX:CUV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
AU |
|
B
|
Bavarian Nordic A/S
OTC:BVNRY
|
DK |
|
Nhoa SA
PAR:NHOA
|
FR |
|
First Business Financial Services Inc
NASDAQ:FBIZ
|
US |
|
HEICO Corp
NYSE:HEI
|
US |
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
AU |
|
M
|
Main Street Capital Corp
SWB:13M
|
US |
|
EchoStar Corp
NASDAQ:SATS
|
US |
|
Vivendi SE
OTC:VIVHY
|
FR |
|
National Australia Bank Ltd
ASX:NAB
|
AU |
|
DoubleVerify Holdings Inc
NYSE:DV
|
US |
|
G50 Corp Ltd
OTC:GFTYF
|
AU |
|
Amaroq Minerals Ltd
XTSX:AMRQ
|
CA |
|
R
|
Rheinmetall AG
SWB:RHM
|
DE |
|
R
|
Rolls-Royce Holdings PLC
OTC:RLLCF
|
UK |
|
Acomo NV
AEX:ACOMO
|
NL |
|
D
|
Danieli & C Officine Meccaniche SpA
MIL:DAN
|
IT |
|
System1 Group PLC
LSE:SYS1
|
UK |
Bankruptcy Probability
Clinuvel Pharmaceuticals Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Clinuvel Pharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
458.3m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
401.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Clinuvel Pharmaceuticals Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Clinuvel Pharmaceuticals Ltd has total debt of 17.3k AUD. This includes both short-term (0 AUD) and long-term (17.3k AUD) debt.
You can find a full breakdown on its Balance Sheet.
